Context-dependent effects of IL-2 rewire immunity into distinct cellular circuits
C. E. Whyte, K. Singh, O. T. Burton, M. Aloulou, A. Moudra, C. P. Roca, F. J. Naranjo, F. Lombard-Vadnais, L. Kouser, T. Hochepied, T. Y. F. Halim, S. Schlenner, S. Lesage, J. Dooley, A. Liston
Abstract
Interleukin 2 (IL-2) is a key homeostatic cytokine, with potential therapeutic applications in both immunogenic and tolerogenic immune modulation. Clinical application has been hampered by pleiotropic functionality and wide-spread receptor expression, with unexpected adverse events during trials. To characterize the IL-2 homeostatic network, we developed a novel mouse strain allowing IL-2 production to be diverted. Rewiring of IL-2 production to diverse leukocyte sources allowed the identification of contextual influences over IL-2 impact. Network analysis identified a priority access for Tregs, and a competitive fitness cost induced among both Tregs and conventional CD4 T cells for IL-2 production. CD8 T cells and NK cells, by contrast, exhibited a preference for autocrine IL-2 production. IL-2 sourced from dendritic cells amplified the Treg circuit, while IL-2 produced by B cells induced two context-dependent circuits: dramatic expansion of CD8+ Tregs and ILC2 cells. The former was associated with an unexpected concentration of rare CD8+ Tregs in B cell zones, while the latter drove a downstream, IL-5-mediated, eosinophilic circuit. The source-specific effects demonstrate the contextual influence of IL-2 function and potentially explain unexpected adverse effects observed during clinical trials of exogenous IL-2. Targeted IL-2 production therefore has the potential to amplify or quench particular circuits in the IL-2 network, based on clinical desirability. Graphical abstract O_FIG_DISPLAY_L [Figure 1] M_FIG_DISPLAY C_FIG_DISPLAY
02 /Specification & Classification
Click any tag to browse matching papersReproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Treg cells maintain selective access to IL-2 and immune homeostasis despite substantially reduced CD25 function
E. T. Hayes, C. E. Hagan, D. J. Campbell·bioRxiv·Dec 24, 2019
- A Dynamically Regulated Designed IL-2 for Tumor-localized Signaling
Howell F. Moffett, Brian D. Weitzner, … Marc J. Lajoie·bioRxiv·Sep 22, 2026
- Targeting IL-2 to inflamed tissues via oxidation-specific epitopes enables third-generation bispecific IL-2 therapeutics
Thomas Vazquez, Monica Cuevas-martinez, … David Klatzmann·bioRxiv·Sep 15, 2026
- Regulatory T cell expansion by a highly CD25-dependent IL-2 mutein arrests ongoing autoimmunity
L. Khoryati, M. N. Pham, … M. A. Gavin·bioRxiv·May 10, 2020
- Multivalent, asymmetric IL-2-Fc fusions provide optimally enhanced regulatory T cell selectivity
Brian T. Orcutt-Jahns, Peter C. Emmel, … Aaron S. Meyer·bioRxiv·Jul 3, 2021
- An IL-2 mutein increases IL-10 and CTLA-4-dependent suppression of dendritic cells by regulatory T cells
Braxton L. Jamison, Matthew F. Lawrance, … Daniel Campbell·Cell ReportsPeer-reviewed·Nov 1, 2024